- Medical - Care Facilities
- Healthcare
-
9.89
EPS
-
14.18
P/E
-
11.8B
MARKET CAP
-
0.00%
DIV YIELD
Company Overview
2000 16TH STREET,DENVER CO 80202,310-536-2668
CEO
Mr. Javier J. Rodriguez
Employess
70000
Sector
Healthcare
Industry
Medical - Care Facilities
Website
https://www.davita.com
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Next Earnings Date
Nov. 5, 2024
Ex Dividends date
--
Dividend Date
--
YTD Performance
31.26%
Fiscal Year End
12-31
IPO Date
1995-10-31
Growth Rates
(avg. rate of change) | 10 years | 5 years | 3 years | 1 year |
---|---|---|---|---|
Sales/Revenue | 0.32% | 1.26% | 1.67% | 4.57% |
EPS | 9.70% | 10.48% | 5.23% | -7.75% |
Equity | -13.36% | -22.19% | -8.61% | 48.26% |
Cash | -6.87% | 7.54% | 12.66% | 90.36% |
Return On Capital (ROIC) | 9.45% | 10.60% | 11.09% | 13.52% |
Debt
year (millions) | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Short Term Debt | 518 | 627 | 573 | 538 | 475 |
Long Term Debt | 8,050 | 11,200 | 11,400 | 10,700 | 10,700 |
LT Finance Leases | 2,550 | 2,900 | 3,070 | 3,110 | 3,070 |
Shares Outstanding | 90.8 | 93 | 105 | 120 | 153 |
Market Cap | 9,510 | 6,940 | 12,000 | 14,100 | 11,500 |
Price
News
DaVita Inc. Announces Pricing of $1.0 Billion Senior Notes Offering
1 monthDENVER , Aug. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today the pricing of its previously announced private offering (the "offering") of $1.0 billion aggregate principal amount of its 6.875% senior notes due 2032 (the "2032 notes"). The 2032 notes were priced at 100.000% of their face amount to yield a 6.875% coupon.
prnewswire.comIs DaVita (DVA) a Great Value Stock Right Now?
1 monthHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zacks.comAre Medical Stocks Lagging DaVita (DVA) This Year?
1 monthHere is how DaVita HealthCare (DVA) and Avadel (AVDL) have performed compared to their sector so far this year.
zacks.comDaVita Inc. Announces Offering of $1.0 Billion Senior Notes
1 monthDENVER , Aug. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering (the "offering") of $1.0 billion aggregate principal amount of its senior notes due 2032 (the "2032 notes"), subject to market and other conditions. DaVita intends to use the net proceeds from the offering to (i) repay a portion of its outstanding Term Loan B-1 facility borrowings maturing in 2026 and a portion of its outstanding revolving credit facility borrowings, in each case, together with related accrued and unpaid interest thereon, (ii) pay any costs, fees and expenses in connection with the foregoing, and (iii) if any proceeds remain, for general corporate purposes, including, without limitation, for repurchases of its capital stock, working capital and capital expenditures.
prnewswire.comDaVita (DVA) Q2 Earnings & Revenues Top Estimates, Margins Up
1 monthDaVita's (DVA) robust segmental revenues drive its second-quarter performance.
zacks.comDaVita HealthCare (DVA) Q2 Earnings and Revenues Surpass Estimates
1 monthDaVita HealthCare (DVA) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.47 per share. This compares to earnings of $2.08 per share a year ago.
zacks.comDaVita Inc. 2nd Quarter 2024 Results
1 monthDENVER , Aug. 6, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2024. "On behalf of all the teammates who provide life-saving care to our patients, I am grateful for the opportunity to report another positive quarter for DaVita," said Javier Rodriguez, CEO of DaVita Inc. "We continue to enhance our clinical capabilities while optimizing our revenue operations and cost structure.
prnewswire.comThe Final Peak Week Of The Q2 Season Begins Amid Souring Economic Data
1 monthThis marks the last peak week of the Q2 earnings season with 3,908 companies expected to report. Earnings have come in better-than-expected, but tend to be overshadowed by economic data. Outlier earnings this week include: CSX, CAT, and VFC.
seekingalpha.comStrength in Kidney Care Likely to Aid DaVita's (DVA) Q2 Earnings
1 monthImprovement in RPT and cost-saving initiatives are likely to have boosted DaVita's (DVA) top line in the second quarter.
zacks.com4 Stocks to Watch From a Challenging Outpatient Home Health Industry
2 monthsDespite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, EHC and ADUS are well-poised to gain.
zacks.comDaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights
2 monthsIn the latest trading session, DaVita HealthCare (DVA) closed at $136.47, marking a -1.93% move from the previous day.
zacks.com2 Warren Buffett small-cap stocks to turn $100 into $1000 by 2025
2 monthsAs the second half of 2024 unfolds, the stock market continues to offer various investment opportunities ranging from large to small-cap equities.
finbold.com